日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial

围手术期以 Penpulimab 为基础的联合疗法治疗可切除非小细胞肺癌患者（ALTER-L043）：一项开放标签、多中心、随机、II 期试验

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02544-w
Wang, Meng; Liu, Weiran; Guo, Hongbo; Long, Hao; Yu, Bentong; Zhao, Guofang; Wu, Jun; Yue, Dongsheng; Zhao, Xiaoliang; Li, Chenguang; Zhang, Lianmin; Wang, Shengguang; Zhang, Qiang; Zhang, Zhenfa; Wang, Changli
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets

RNA调控网络：癌症全貌中的关键枢纽和新兴治疗靶点

期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70586
Yin, Xuan; Du, Zengkan; Jiang, Shuya; Liao, Yan; Wang, Changli; Li, Jiaqi; Zhang, Haoling; Wei, Ting-Ting; Zhang, Wangzheqi; Zou, Zui
信号转导
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

DNA and RNA editing for the therapy of human diseases: current status, challenges, and future prospects

DNA和RNA编辑在人类疾病治疗中的应用：现状、挑战和未来展望

期刊:Molecular Biomedicine
影响因子:10.1
doi:10.1186/s43556-026-00456-x
Zhao, Rui; Wang, Changli; Li, Jiamei; Liao, Yan; Huang, Chenwei; Hu, Ting; Zhang, Haoling; Zhang, Wangzheqi
发表日期：2026
文献求助 收藏

GPR43 alleviates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome activation via β-arrestin 2.

GPR43 通过 β-arrestin 2 抑制 NLRP3 炎症小体的激活，从而减轻 LPS 诱导的急性肺损伤。

期刊:Biology Direct
影响因子:4.9
doi:10.1186/s13062-025-00725-9
Wang Changli, Zhang Wangzheqi, Guo Yu, Liao Yan, Li Na, Zhang Yan, Bo Lulong, Bian Jinjun, Wang Jia-Feng
炎症
炎性小体
炎症/感染
LRP3
NLRP3
炎性小体
免疫/内分泌
发表日期：2026
文献求助 收藏

Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer

可切除肺癌新辅助治疗中，纳武利尤单抗联合伊匹木单抗与化疗的比较

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-24-02239
Awad, Mark M; Forde, Patrick M; Girard, Nicolas; Spicer, Jonathan; Wang, Changli; Lu, Shun; Mitsudomi, Tetsuya; Felip, Enriqueta; Broderick, Stephen R; Swanson, Scott J; Brahmer, Julie; Kerr, Keith; Saylors, Gene B; Chen, Ke-Neng; Gharpure, Vishwanath; Neely, Jaclyn; Balli, David; Hu, Nan; Provencio Pulla, Mariano
肺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Cell death signaling and immune regulation: new perspectives on targeted therapy for sepsis

细胞死亡信号传导与免疫调节：脓毒症靶向治疗的新视角

期刊:Cellular & Molecular Biology Letters
影响因子:10.2
doi:10.1186/s11658-025-00784-w
Wu, Huang; Cui, Jiale; Huang, Jie; Feng, Yuqi; Zhao, Jiaxin; Zhu, Yalin; Deng, Xiaoming; Li, Xinyu; Zhang, Wangzheqi; Wang, Changli
炎症/感染
信号转导
败血症
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Autophagy: a double-edged sword in ischemia-reperfusion injury

自噬：缺血再灌注损伤中的一把双刃剑

期刊:Cellular & Molecular Biology Letters
影响因子:10.2
doi:10.1186/s11658-025-00713-x
Tang, Lingxuan; Zhang, Wangzheqi; Liao, Yan; Wang, Weijie; Deng, Xiaoming; Wang, Changli; Shi, Wenwen
Autophagy
自噬
发表日期：2025
文献求助 收藏

Osimertinib plus anlotinib for advanced NSCLC with acquired EGFR T790M mutation: results from a multicenter phase II study with ctDNA analysis

奥希替尼联合安罗替尼治疗获得性EGFR T790M突变的晚期非小细胞肺癌：一项多中心II期临床研究及ctDNA分析结果

期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-025-04044-8
Wang, Xinyue; Li, Zhaona; Wang, Liuchun; Liang, Yan; Huang, Chun; Chen, Peng; Huang, Dingzhi; Song, Xia; Ding, Cuimin; Wang, Changli; Jiang, Richeng
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

BAP31 Promotes Epithelial-Mesenchymal Transition Progression Through the Exosomal miR-423-3p/Bim Axis in Colorectal Cancer

BAP31通过外泌体miR-423-3p/Bim轴促进结直肠癌上皮-间质转化进程

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26125483
Wang, Changli; Liu, Wanting; Yang, Sheng; Wang, Tianyi; Wang, Bing
外泌体
肿瘤
肠癌
肿瘤免疫
BAP31
发表日期：2025
文献求助 收藏

The Intrabody Against Murine Double Minute 2 via a p53-Dependent Pathway Induces Apoptosis of Cancer Cell.

针对鼠双微体 2 的胞内抗体通过 p53 依赖性途径诱导癌细胞凋亡

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26115286
Wang Changli, Liu Wanting, Guo Haotian, Lan Tian, Wang Tianyi, Wang Bing
细胞生物学
Apoptosis
P53
凋亡
发表日期：2025
文献求助 收藏